Testbiotech Background: Comment on EFSA draft document on risk assessment of plants developed with Type 1 (SDN-1) and Type 2 (SDN-2) site-directed nucleases and oligonucleotide directed mutagenesis (ODM) (May 2020)

Publication year: 
2020
File attachments: 
AttachmentSize
PDF icon TBT_Background_on_SDN_Consultation.pdf106.99 KB